⌘K

Login Start Free

Home/Filings/4/0001855763-21-000007

4//SEC Filing

Downey Gregory 4

Accession 0001855763-21-000007

CIK 0001348362other

View on SEC.gov Company Profile

Filed

Apr 26, 8:00 PM ET

Accepted

Apr 27, 5:21 PM ET

Size

10.6 KB

Accession

0001855763-21-000007

Insider Transaction Report

Form 4

Period: 2021-04-26

Lexaria Bioscience Corp.LEXX

Chief Financial Officer

Transactions

Award
Stock Options
2021-04-26+5,000→ 25,000 total
Exercise: $5.31From: 2022-04-26Exp: 2026-04-26→ Common Shares (5,000 underlying)

Holdings

common shares
1,833
Stock Options
Exercise: $9.60From: 2020-04-23Exp: 2025-04-23→ Common Shares (8,000 underlying)
8,000
Stock Options
Exercise: $5.04From: 2021-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
12,000
Stock Options
Exercise: $5.04From: 2022-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
16,000
Stock Options
Exercise: $5.04From: 2023-04-15Exp: 2026-04-15→ Common Shares (4,000 underlying)
20,000

Documents

1 file

4
primary_doc.xmlPrimary
PRIMARY DOCUMENT

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

Entity typeother

Related Parties

1

filerCIK 0001855801

Filing Metadata

Form type: 4
Filed: Apr 26, 8:00 PM ET
Accepted: Apr 27, 5:21 PM ET
Size: 10.6 KB

View on SEC.gov